Christopher Dejesus

Scientist II at Atalanta Therapeutics - Boston, MA, US

Christopher Dejesus's Colleagues at Atalanta Therapeutics
Kailene Simon

Associate Director, Head of In Vitro Biology

Contact Kailene Simon

Daniel Ph.D.

Vice President Research and Development

Contact Daniel Ph.D.

Aimee Jackson

Chief Scientific Officer

Contact Aimee Jackson

Maurice Smith

Senior Director, Controller

Contact Maurice Smith

Mingwei Li

Scientific Technical Leader I

Contact Mingwei Li

View All Christopher Dejesus's Colleagues
Christopher Dejesus's Contact Details
HQ
N/A
Location
Bronx, Nueva York, Estados Unidos
Company
Atalanta Therapeutics
Christopher Dejesus's Company Details
Atalanta Therapeutics logo, Atalanta Therapeutics contact details

Atalanta Therapeutics

Boston, MA, US • 50 - 99 Employees
Biotech/Healthcare

We are a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D., of the RNA Therapeutics Institute at the University of Massachusetts Medical School, with a Series A funding exclusively by F-Prime Capital. We are headquartered in Boston, Mass.

N/A
Details about Atalanta Therapeutics
Frequently Asked Questions about Christopher Dejesus
Christopher Dejesus currently works for Atalanta Therapeutics.
Christopher Dejesus's role at Atalanta Therapeutics is Scientist II.
Christopher Dejesus's email address is ***@atalantatx.com. To view Christopher Dejesus's full email address, please signup to ConnectPlex.
Christopher Dejesus works in the Biotech/Healthcare industry.
Christopher Dejesus's colleagues at Atalanta Therapeutics are Kailene Simon, Daniel Ph.D., Aimee Jackson, Maurice Smith, Corrie Gallant-Behm, Mingwei Li, Alexander Saunders and others.
Christopher Dejesus's phone number is N/A
See more information about Christopher Dejesus